High Growth Tech Stocks To Watch In November 2024

In This Article:

In the last week, the United States market has stayed flat; however, it is up 33% over the past year with earnings forecasted to grow by 15% annually. In this environment, identifying high growth tech stocks involves looking for companies that can capitalize on strong earnings potential and sustain momentum in a rapidly evolving sector.

Top 10 High Growth Tech Companies In The United States

Name

Revenue Growth

Earnings Growth

Growth Rating

Sarepta Therapeutics

23.89%

42.65%

★★★★★★

Invivyd

47.87%

67.72%

★★★★★★

TG Therapeutics

34.66%

56.48%

★★★★★★

Alkami Technology

21.89%

98.60%

★★★★★★

Alnylam Pharmaceuticals

22.45%

70.66%

★★★★★★

Blueprint Medicines

25.26%

68.92%

★★★★★★

Travere Therapeutics

31.19%

72.58%

★★★★★★

Cloudflare

20.51%

23.80%

★★★★★★

Seagen

22.57%

71.80%

★★★★★★

ImmunoGen

26.00%

45.85%

★★★★★★

Click here to see the full list of 246 stocks from our US High Growth Tech and AI Stocks screener.

Here we highlight a subset of our preferred stocks from the screener.

MongoDB

Simply Wall St Growth Rating: ★★★★☆☆

Overview: MongoDB, Inc., along with its subsidiaries, offers a general-purpose database platform globally and has a market capitalization of approximately $21.54 billion.

Operations: The company generates revenue primarily from its data processing segment, amounting to $1.82 billion.

MongoDB, a key figure in the tech industry, is navigating through unprofitable waters with a net loss of $54.53 million in Q2 2024, widening from the previous year. Despite these challenges, it forecasts robust annual revenue growth at 15.4%, outpacing the US market's 9%. The company's commitment to innovation is evident in its R&D spending which has been strategically aligned with its growth trajectory; however, specific figures were not disclosed. Recent integrations like MongoDB Atlas-PowerSync highlight its focus on enhancing data synchronization technologies for developers, ensuring MongoDB remains at the forefront of database solutions and cloud services. This strategic direction not only addresses immediate application performance needs but also sets the stage for future profitability and sustained growth in an increasingly digital economy.

NasdaqGM:MDB Earnings and Revenue Growth as at Nov 2024
NasdaqGM:MDB Earnings and Revenue Growth as at Nov 2024

Veracyte

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Veracyte, Inc. is a diagnostics company that operates both in the United States and internationally, with a market capitalization of approximately $2.96 billion.

Operations: Veracyte generates revenue primarily through its diagnostic products, amounting to $425.33 million.